NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,697 Cr | ₹1,212 Cr | ₹849 Cr | ₹47 Cr | ₹299 Cr |
What is the latest Cash Flow from Operating Activities ratio of NATCO PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1,697 Cr |
| Mar2024 | ₹1,212 Cr |
| Mar2023 | ₹849 Cr |
| Mar2022 | ₹47 Cr |
| Mar2021 | ₹299 Cr |
How is Cash Flow from Operating Activities of NATCO PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,697 Cr | 40.05 | |
| Mar2024 | ₹1,212 Cr | 42.69 | |
| Mar2023 | ₹849 Cr | 1,726.02 | |
| Mar2022 | ₹47 Cr | -84.44 | |
| Mar2021 | ₹299 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹16,456.6 Cr | 1.7% | -23.9% | 1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 1.7% |
-23.9% |
1.4% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses